Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer-Reference-Cited by-同舟云学术

Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer

Published:2023-01-02 Issue:1 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Qiu Xin¹²,Shi Zhan¹,Tong Fan²,Lu Changchang²,Zhu Yahui¹,Wang Qiaoli¹,Gu Qing³,Qian Xiaoping¹,Meng Fanyan¹,Liu Baorui¹,Du Juan¹²

Affiliation:

1. The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, China

2. The Comprehensive Cancer Center of Drum Tower Hospital, Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China

3. National Institute of Healthcare Data Science, Nanjing University, Nanjing, China

Funder

National Natural Science Foundation of China

Special Fund of Health Science and Technology Development of Nanjing

Beijing Medical Award Foundation

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2023.2178791

Reference39 articles.